02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

684A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

lipopolysaccharides (LPS) contained in normal portal blood<br />

are one of the factors about the development of NASH. Two<br />

major pathway for LPS have been suggested in some <strong>studies</strong>,<br />

which are referred to as MyD88-dependent and –independent<br />

pathways. We aimed to determine the effects of sitagliptin on<br />

the development of LPS-induced NAFLD in ob/ob mice with<br />

diet-induced obesity and T2DM. Methods: Five-week-old male<br />

ob/ob mice, which develop T2DM and NAFLD by taking a<br />

high-carbohydrate diet (HCD), were divided into a group in<br />

which a HCD was given for 8 weeks and treated with LPS<br />

(n=6) as controls (Control group), and another in which a HCD<br />

added with 0.0018% sitagliptin was given for 8 weeks and<br />

treated with LPS (n=6) (Sitagliptin group). Results: Histological<br />

examination demonstrated that this protocol induced steatosis<br />

in the livers of two group mice, however severe fatty droplets<br />

were significantly observed in Control group, compared<br />

with Sitagliptin group. Sitagliptin group showed a decrease<br />

in serum ALT and triglyceride, in addition, hepatic mRNA<br />

expression levels of SREBP-1c, FAS and peroxisome PPARγ<br />

were decreased in Sitagliptin group. Furthermore, Sitagliptin<br />

inhibits the mRNA expression levels of proinflammatory gene<br />

such as TNF-α. Interestingly, hepatic mRNA expression levels of<br />

MyD88 and NFκB were decreased in Sitagliptin group. These<br />

finding coincided with histological findings and the results of<br />

biochemical examination. Conclusion: Our findings indicated<br />

that sitagliptin could be preventative drug for the development<br />

of LPS-induced NAFLD and MyD88-dependent pathway.<br />

Disclosures:<br />

The following authors have nothing to disclose: Keisuke Yokohama, Shinya<br />

Fukunishi, Sanomura Makoto, Akira Asai, Yasuhiro Tsuds, Kazuhide Higuchi<br />

967<br />

DSS colitis has tumorinogenesis and fibrogenesis in choline-deficiency<br />

and high-fat diet induced NASH mouse<br />

model<br />

Koichi Achiwa, Masatoshi Ishigami, Yoji Ishizu, Teiji Kuzuya,<br />

Takashi Honda, Kazuhiko Hayashi, Yoshiki Hirooka, Hidemi Goto;<br />

Gastroenterology and Hepatology, Nagoya Univercity Graduate<br />

School of Medicine, Nagoya, Japan<br />

Background and Aim Non-alcoholic steatohepatitis (NASH)<br />

patients progress to liver cirrhosis and even hepatocellular carcinoma(HCC).<br />

Several line of evidence indicated that accumulation<br />

of lipopolysaccharide (LPS) plays a contributory role in<br />

the pathogenesis HCC by eliciting proinflammatory response in<br />

the liver. Moreover, it has been reported that dextran sodium<br />

sulfate (DSS) induced colitis mouse model fed high fat diet<br />

increased portal LPS and developed hepatic inflammation and<br />

fibrosis. However, diet induced NASH model with carcinogenesis<br />

require over 50 weeks or more. The purpose of this study<br />

was to create a novel tumorigenesis in diet induced NASH<br />

with DSS administration. Methods 20-week-age C57BL/6<br />

mice were fed choline-deficiency and high-fat diet (CDHF) for<br />

4 and 12 weeks. DSS group was fed CDHF and 1% DSS in<br />

the drinking water intermittently. On the other hand control<br />

group was fed CDHF and free water supply. We evaluated the<br />

liver tumorigenesis. Hepatic lipid was measured and inflammatory<br />

and fibrosis factors and histological changes were evaluated.<br />

Results Exposure of DSS led to increase mucosal change<br />

such as crypt loss and increase of inflammatory cells in colon.<br />

Accordingly, the histological score significantly increased in<br />

DSS group than control group. But a few colon tissues were<br />

increased inflammatory cells at 12 week in control group.<br />

CDHF led to slightly cause intestinal inflammation. Portal LPS<br />

levels were increased in DSS group comparing with control<br />

group at 4 week, whereas there was no significant difference<br />

in both groups at 12week. Hepatic triglyceride, total and free<br />

cholesterol were increased in the DSS group comparing with<br />

control group at 4 week, whereas there was no significant<br />

difference in both groups at 12 week. Both groups showed<br />

severe macrovesicular steatosis in liver histology. Serum total<br />

bilirubin levels were significantly higher in DSS group than that<br />

in control group. Serum transaminase levels are higher in DSS<br />

group than that in control group. A large number of lobular<br />

inflammatory cells were seen in DSS group. The image analysis<br />

showed significant elevation of F4/80 staining positive area in<br />

DSS group comparing with control group. Fibrosis is increased<br />

in DSS group compared to control group. Liver tumors were<br />

developed in the DSS group of 12-week, while tumor was not<br />

found in the DSS group of 4-week and in the control group.<br />

One of tumors showed highly differentiated hepatocellular carcinoma.<br />

Conclusions DSS administration developed liver tumors<br />

in CDHF induced NASH mouse at the short term. Induction of<br />

intestinal inflammation in NASH may promote hepatic tumorigenesis.<br />

Disclosures:<br />

Hidemi Goto - Grant/Research Support: MSD, Roche, Bayer, Bristol-Myers, Eisai,<br />

Ajinomoto, Otsuka, Astra, Tanabe, Takeda<br />

The following authors have nothing to disclose: Koichi Achiwa, Masatoshi Ishigami,<br />

Yoji Ishizu, Teiji Kuzuya, Takashi Honda, Kazuhiko Hayashi, Yoshiki<br />

Hirooka<br />

968<br />

Inhibition of Mitophagy in Non-alcoholic Steatohepatitis<br />

lead to Apoptosis and Inflammation<br />

Muhammad Sohail 1 , Seong-Jun Kim 2 , Aleem Siddiqui 2 ; 1 GASTRO-<br />

ENTEROLOGY, university of California, San Diego, CA; 2 Infectious<br />

Disease, University of California, San Diego, CA<br />

Background: Fatty liver is benign but it can progress to Non-Alcoholic<br />

Steatohepatitis (NASH) and liver cirrhosis. Mitochondria<br />

are dynamic organelles that constantly undergo fission,<br />

fusion, and mitophagy to facilitate mitochondrial quality control,<br />

which is crucial for maintaining cell viability and bioenergetics.<br />

Mitochondrial fission/fragmentation is mediated<br />

by recruitment of cytosolic Drp1 to the mitochondria forming<br />

spirals that constrict both the inner and outer mitochondrial<br />

membranes. Drp1 recruitment to mitochondria is regulated by<br />

phosphorylation and dephosphorylation of respective serine<br />

residues by putative kinases and phosphatases. Mitochondrial<br />

dynamics is tightly regulated in response to alterations<br />

in cellular physiology and its dysfunction occurs in NASH.<br />

Methods Palmitic acid (PA) is able to reproduce in vitro model<br />

for fatty liver disease. To investigate the mitochondrial fission<br />

and mitophagy, the human hepatoma Huh7 cells cultured in<br />

the presence or absence of PA were observed by confocal<br />

microscope. PA-induced stimulation and mitochondrial translocation<br />

of dynamin-related protein 1 (Drp1) and Parkin, two<br />

key factors of mitochondrial fission and mitophagy, were analyzed<br />

by Western blot using purified mitochondria fraction<br />

and confocal microscope. The liver tissues extracted from highfat<br />

diet-fed C57BL/6 mice and biopsy samples from Human<br />

NASH patients were also used for analysis of Drp1 and Parkin<br />

activation. Small interfering RNA-mediated Drp1 and Parkin<br />

silencing strategy was further employed for further analysis of<br />

PA-induced mitochondrial fission and mitophagy and alteration<br />

in inflammatory response. Results: PA stimulated Drp1 gene<br />

expression and induced mitochondrial translocation of Drp1<br />

via promoting both its phosphorylation (Ser616) and dephosphorylation<br />

(Ser637) followed by mitochondrial fission. These<br />

results were confirmed in liver tissue extracted from high-fat<br />

diet-fed C57BL/6 mice and also in human NASH liver biopsy<br />

tissue. While PA induced Parkin gene expression, mitophagy

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!